ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $63,000 | +8.6% | 15,247 | -6.5% | 0.00% | +50.0% |
| Q4 2021 | $58,000 | +1.8% | 16,313 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | -20.8% | 15,650 | -4.0% | 0.00% | 0.0% |
| Q2 2021 | $72,000 | +111.8% | 16,300 | +27.7% | 0.00% | +100.0% |
| Q2 2014 | $34,000 | -19.0% | 12,765 | +6.4% | 0.00% | -50.0% |
| Q1 2014 | $42,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |